RxDoctor Payments Data

Sobha Paluvoi, MD

Psychiatry · Lansdowne, VANPI 1851578850

Payments from drug & device makers

$1,278in general payments, 2019–2025

Across 66 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$210
  • Otsuka America Pharmaceutical, Inc.$127
  • Novo Nordisk$97
  • Pfizer$97
  • Lundbeck LLC$76
  • AbbVie$68
  • plus $603 from 21 others

What the payments were for

  • Food & beverage$1,23196%
  • Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,278 in reported general payments places this provider in the 75th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$128,559
Medicare patients
272
Services billed
1,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$29,679
VraylarCariprazine Hcl19$25,667
TrintellixVortioxetine Hydrobromide25$20,260
Lisdexamfetamine Dimesylate38$9,708
Lurasidone Hcl18$7,292
Bupropion XlBupropion Hcl219$5,130
VyvanseLisdexamfetamine Dimesylate12$5,124
Duloxetine Hcl235$4,286
Desvenlafaxine Succinate ErDesvenlafaxine Succinate64$3,974
Quetiapine Fumarate234$3,858
Venlafaxine Hcl ErVenlafaxine Hcl105$3,731
Aripiprazole109$3,306
Escitalopram Oxalate266$2,825
Clonazepam205$2,624
Doxepin Hcl60$1,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$127$29,67911 claims
AbbVieVraylar$68$25,66719 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$210$25,38437 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Lansdowne

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →